# Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD)

> **NCT04223518** · EARLY_PHASE1 · TERMINATED · sponsor: **Monisha Hitesh Shah** · enrollment: 6 (actual)

## Conditions studied

- Inflammatory Bowel Diseases
- Ulcerative Colitis
- Crohn Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Serum bovine immunoglobulin
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT04223518
- **Lead sponsor:** Monisha Hitesh Shah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-09-20
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Lack of study participants
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04223518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04223518, "Serum Bovine Immunoglobulin (SBI) in Children and Young Adults With Inflammatory Bowel Disease (IBD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04223518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*